Z7 |
Wild type |
Resistant |
Aggressive |
Normal |
27 |
Δtsa1 mutant |
Impaired thioredoxin peroxidase |
Sensitive |
Reduced |
Normal |
This study |
CPTsa1 |
AaTsa1 complementation |
Resistant |
Aggressive |
Normal |
This study |
Δtrr1 mutant |
Impaired thioredoxin reductase |
Sensitive |
Reduced substantially |
Inhibited |
This study |
CPTrr1 |
AaTrr1 complementation |
Resistant |
Aggressive |
Normal |
This study |
Δglr1 mutant |
Impaired glutathione reductase |
Sensitive |
Reduced |
Inhibited |
This study |
ΔnoxA mutant |
Impaired NADPH oxidase NoxA |
Sensitive |
Reduced |
Inhibited |
48 |
ΔnoxB mutant |
Impaired NADPH oxidase NoxB |
Sensitive |
Reduced |
Inhibited |
25 |
ΔnoxR mutant |
Impaired NADPH oxidase NoxR |
Sensitive |
Reduced |
Inhibited |
25 |
ΔnoxAB mutant |
Impaired NADPH oxidases NoxA and NoxB |
Sensitive |
Not determined |
Inhibited |
25 |
ΔnoxAR mutant |
Impaired NADPH oxidases NoxA and NoxR |
Sensitive |
Not determined |
Inhibited |
25 |
Δhog1 mutant |
Impaired HOG1 MAP kinase |
Sensitive |
Reduced substantially |
Inhibited |
23 |
Δyap1 mutant |
Impaired transcriptional regulator YAP1 |
Sensitive |
Reduced substantially |
Inhibited |
22 |
Δskn7 mutant |
Impaired SKN7 response regulator |
Sensitive |
Reduced |
Inhibited |
24 |